A recent study found that participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...
Discover why doctors warn against vaping for people with these five health conditions including asthma, heart disease, and ...
OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024More prescriptions filled through February ...
Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...
Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...
Genetic risk scoring improves COPD detection beyond traditional methods, enabling earlier diagnosis and better patient ...
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results